This project received funding from the European Union / Grant Agreement Number pending.
Euro-BioImaging is part of ILLUMINATE (Increasing lutetium production while leveraging metabolic imaging to enhance theranostics effectiveness), a pioneering 54-month public-private partnership collaborative research program funded by the Innovative Health Initiative (IHI, https://www.ihi.europa.eu/apply-funding/ihi-call-5 ) that combines research and pre-clinical development. ILLUMINATE will provide the first clinical translation of MeMRI, with application to castrate resistant metastatic prostate cancer. This breakthrough could lead to earlier cancer detection and more effective treatments for various cancer types, offering new tools for medical teams and new hope for patients.
Coordinated by Prof. Dennis Klomp from UMC Utrecht (Dutch High Field MR Node), ILLUMINATE is a collaborative effort that gathers 15 public and private partners from five countries (Netherlands, Finland, Germany, Italy and Sweden): six industrial partners (imaging instrumentation and pharma), three Nodes (a second facility from the Dutch High Field MR Node, three facilities from the MMMI Node and one facility from the NMI Node), two research organisations and a project management company.
In ILLUMINATE, Euro-BioImaging is engaged in Work Package 5, "Patient and Public Engagement & Education for Healthcare Professionals and Scientists", and Work Package 6 ", Programme Management and Communications". Euro-BioImaging is leading task 5.5 on "Educational activities and scientific dissemination", aiming to build efficient communication of the programme's achievements to healthcare professionals and scientists through available channels, including live events and online workshops serving as advanced training for end-users and researchers. Euro-BioImaging is also leading Task 6.4 "Communication and dissemination".
The programme's total budget is 21M€ (11.6M€ from the European Commission, 6.1M€ from industrial partners, and 3.6M€ from contributing partners), of which 4,6M€ are earmarked for the Nodes.
ILLUMINATE brings together private-public partners to advance novel theranostics-based cancer treatments
Euro-BioImaging is thrilled to be part of ILLUMINATE (Increasing Lutetium production while leveraging metabolic imaging to enhance theranostics effectiveness), a pioneering 54-month public-private partnership…